Getting Stem Cell Therapies Approved: Ann Tsukamoto - CIRM Science Writer's Seminar

Ann Tsukamoto, Ph.D., spoke at the Scientific Writer’s Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Tsukamoto is the Chief Operating Officer at Stem Cells, Inc., a Palo Alto based company that, at the time of this video recording, had begun a stem cell based human clinical trial for the treatment of Batten disease. Tsukamoto reviewed the process of getting the therapy approved for the clinical trial.

Disease Programs

Learn about how CIRM-funded stem cell research could generate treatments for many chronic diseases and injuries.

See disease fact sheets

CIRM Stem Cell Blog